Physician profile
Caroline Kingston
NPI 1750489811
$875.31
in general payments reported to CMS, 2019-2025
18 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.89 · 2020: $123 · 2021: $12.76 · 2022: $20.32 · 2023: $222 · 2024: $324 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $182.51 | 2023-2024 | |
| Exact Sciences Corporation | $97.48 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $84.53 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $61.31 | 2020-2021 | |
| Pfizer INC. | $58.19 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $55.83 | 2024-2025 | Breztri |
| Ibsa Pharma INC. | $44.53 | 2024-2025 | Licart, Tirosint, Flector |
| Boston Scientific Corporation | $40.31 | 2025 | Watchman Access System |
| Allergan, INC. | $37.44 | 2019-2020 | |
| Amarin Pharma, INC. | $36.85 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $31.26 | 2024-2025 | Rexulti |
| Novo Nordisk INC | $29.68 | 2023-2025 | Wegovy |
| Astellas Pharma US INC | $28.13 | 2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.91 | 2024 | |
| Glaxosmithkline, LLC. | $20.33 | 2023 | Arexvy, Shingrix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $19.38 | 2024 | Voquezna |
| Linus Health, INC. | $12.93 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $11.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Kingston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.